Xenon Pharmaceuticals (XENE)
(Delayed Data from NSDQ)
$40.09 USD
0.00 (0.00%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $40.07 -0.02 (-0.05%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -0.85 |
EPS Last Quarter | -0.75 |
Last EPS Surprise | -4.17% |
ABR | 1.12 |
Earnings ESP
|
1.47% |
---|---|
Current Year | -3.16 |
Next Year | -3.75 |
EPS (TTM) | -2.74 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 75.00M |
# of Estimates | NA | NA | NA | 1 |
High Estimate | NA | NA | NA | 75.00M |
Low Estimate | NA | NA | NA | 75.00M |
Year ago Sales | 0.00M | 0.00M | 9.43M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.85 | -0.91 | -3.16 | -3.75 |
# of Estimates | 8 | 6 | 10 | 9 |
Most Recent Consensus | -0.84 | -0.88 | -3.09 | -3.73 |
High Estimate | -0.76 | -0.78 | -2.87 | -2.55 |
Low Estimate | -0.99 | -1.09 | -3.44 | -4.28 |
Year ago EPS | -0.73 | -0.64 | -2.73 | -3.16 |
Year over Year Growth Est. | -16.44% | -42.19% | -15.75% | -18.61% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 5 | 6 | 8 | 6 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.85 | -0.91 | -3.16 | -3.75 |
7 Days Ago | -0.85 | -0.91 | -3.16 | -3.75 |
30 Days Ago | -0.85 | -0.91 | -3.16 | -3.75 |
60 Days Ago | -0.77 | -0.77 | -2.98 | -3.41 |
90 Days Ago | -0.77 | -0.77 | -2.98 | -3.41 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.84 | -0.88 | -3.09 | -3.73 |
Zacks Consensus Estimate | -0.85 | -0.91 | -3.16 | -3.75 |
Earnings ESP | 1.47% | 3.12% | 2.28% | 0.53% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.75 | -0.62 | -0.64 | -0.73 | NA |
Estimate | -0.72 | -0.69 | -0.76 | -0.75 | NA |
Difference | -0.03 | 0.07 | 0.12 | 0.02 | 0.05 |
Surprise | -4.17% | 10.14% | 15.79% | 2.67% | 6.11% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more